Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

19.83

-1.18 (-5.62%)

At close: Mar 3, 2026, 4:00 PM EST

20.34

+0.51 (2.57%)

After-hours: Mar 3, 2026, 7:01 PM EST

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	719.89	712.81	593.24	498.99	437.77
Other Revenue	-	19.15	51.16	-	-
Revenue	719.89	731.97	644.4	498.99	437.77
Revenue Growth (YoY)	-1.65%	13.59%	29.14%	13.98%	25.13%
Cost of Revenue	363.83	358.11	290.57	250.13	238.03
Gross Profit	356.06	373.86	353.82	248.86	199.74
Selling, General & Admin	106.71	94.52	80.39	66.59	67.12
Research & Development	85.84	73.91	73.74	74.77	60.93
Operating Expenses	192.55	168.44	154.13	141.36	128.05
Operating Income	163.5	205.42	199.69	107.5	71.69
Interest Expense	-29.78	-35.34	-33.06	-1.85	-0.89
Interest & Investment Income	8.68	10.61	5.46	1.32	0.6
Earnings From Equity Investments	-	-0.57	-1.98	-1.18	-0.21
Currency Exchange Gain (Loss)	4	-1.9	1.1	-	-
Other Non Operating Income (Expenses)	0.32	10.98	0.87	9.07	13.54
EBT Excluding Unusual Items	146.72	189.19	172.08	114.86	84.73
Asset Writedown	-	-	-2.7	-	-
Legal Settlements	-23.1	-	-	-	1
Other Unusual Items	-	-	-	-	-1.8
Pretax Income	123.62	189.19	169.38	114.86	83.93
Income Tax Expense	25.53	29.67	31.83	23.48	20.63
Earnings From Continuing Operations	98.09	159.52	137.55	91.39	63.3
Minority Interest in Earnings	-	-	-	-	-1.19
Net Income	98.09	159.52	137.55	91.39	62.12
Net Income to Common	98.09	159.52	137.55	91.39	62.12
Net Income Growth	-38.51%	15.98%	50.51%	47.12%	4327.37%
Shares Outstanding (Basic)	47	48	48	49	48
Shares Outstanding (Diluted)	48	52	53	52	50
Shares Change (YoY)	-7.38%	-1.78%	1.09%	5.31%	1.34%
EPS (Basic)	2.10	3.29	2.85	1.88	1.30
EPS (Diluted)	2.03	3.06	2.60	1.74	1.25
EPS Growth	-33.66%	17.69%	49.43%	39.20%	4090.97%
Free Cash Flow	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Per Share	2.51	3.31	2.74	1.24	1.42
Gross Margin	49.46%	51.08%	54.91%	49.87%	45.63%
Operating Margin	22.71%	28.06%	30.99%	21.54%	16.38%
Profit Margin	13.63%	21.79%	21.34%	18.31%	14.19%
Free Cash Flow Margin	16.84%	23.54%	22.55%	13.06%	16.11%
EBITDA	220.2	258.39	237.72	132.27	94.95
EBITDA Margin	30.59%	35.30%	36.89%	26.51%	21.69%
D&A For EBITDA	56.7	52.97	38.04	24.77	23.27
EBIT	163.5	205.42	199.69	107.5	71.69
EBIT Margin	22.71%	28.06%	30.99%	21.54%	16.38%
Effective Tax Rate	20.65%	15.68%	18.79%	20.44%	24.58%
Revenue as Reported	719.89	731.97	644.4	498.99	437.77
Advertising Expenses	10.2	10.5	10.4	8.7	8.1

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q